Aldeyra to challenge FDA rejection of dry eye drug reproxalap
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq futures drop over 1% as AI worries resurface, oil climbs
- Oil jumps on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
| ALDEYRA THERAPEUT (NASDAQ: ALDX) | Delayed: 0.67 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.67 | 52 Week High | $8.19 | |||
| Open | $0.67 | 52 Week Low | $3.39 | |||
| Day High | $0.67 | P/E | N/A | |||
| Day Low | $0.67 | EPS | $0.00 | |||
| Volume | 350 | |||||
